NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 254 filers reported holding NATERA INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,740,677 | -4.6% | 1,191,879 | +4.9% | 0.01% | 0.0% |
Q2 2023 | $55,286,503 | -20.9% | 1,136,179 | -9.7% | 0.01% | -28.6% |
Q1 2023 | $69,859,687 | +35.4% | 1,258,279 | -2.0% | 0.01% | +16.7% |
Q4 2022 | $51,602,529 | +28.9% | 1,284,603 | +40.6% | 0.01% | +20.0% |
Q3 2022 | $40,023,000 | +4.2% | 913,369 | -15.7% | 0.01% | 0.0% |
Q2 2022 | $38,420,000 | +42.8% | 1,084,099 | +63.9% | 0.01% | +25.0% |
Q1 2022 | $26,909,000 | +20.5% | 661,480 | +176.5% | 0.00% | +33.3% |
Q4 2021 | $22,339,000 | -28.7% | 239,220 | -14.9% | 0.00% | -25.0% |
Q3 2021 | $31,316,000 | -10.7% | 281,018 | -9.0% | 0.00% | -20.0% |
Q2 2021 | $35,070,000 | +42.0% | 308,906 | +27.0% | 0.01% | +25.0% |
Q1 2021 | $24,697,000 | -4.0% | 243,232 | -5.9% | 0.00% | 0.0% |
Q4 2020 | $25,717,000 | +150.8% | 258,402 | +82.0% | 0.00% | +100.0% |
Q3 2020 | $10,256,000 | +6.0% | 141,980 | -26.8% | 0.00% | 0.0% |
Q2 2020 | $9,675,000 | +53.2% | 194,034 | -8.2% | 0.00% | 0.0% |
Q1 2020 | $6,314,000 | -65.2% | 211,459 | -60.8% | 0.00% | -50.0% |
Q4 2019 | $18,151,000 | +24.6% | 538,759 | +21.3% | 0.00% | 0.0% |
Q3 2019 | $14,562,000 | +148.2% | 443,977 | +108.8% | 0.00% | +100.0% |
Q2 2019 | $5,866,000 | +20.7% | 212,672 | -9.8% | 0.00% | +100.0% |
Q1 2019 | $4,859,000 | +8.6% | 235,650 | -26.5% | 0.00% | 0.0% |
Q4 2018 | $4,474,000 | -25.7% | 320,449 | +27.4% | 0.00% | -50.0% |
Q3 2018 | $6,020,000 | +24.5% | 251,447 | -2.1% | 0.00% | +100.0% |
Q2 2018 | $4,836,000 | +75.9% | 256,959 | -13.4% | 0.00% | 0.0% |
Q1 2018 | $2,750,000 | +13.3% | 296,643 | +9.8% | 0.00% | 0.0% |
Q4 2017 | $2,428,000 | -26.8% | 270,077 | +5.0% | 0.00% | 0.0% |
Q3 2017 | $3,315,000 | +30.1% | 257,199 | +9.6% | 0.00% | 0.0% |
Q2 2017 | $2,549,000 | -25.6% | 234,740 | -39.3% | 0.00% | 0.0% |
Q1 2017 | $3,428,000 | -48.4% | 386,494 | -31.9% | 0.00% | 0.0% |
Q4 2016 | $6,640,000 | +1006.7% | 567,276 | +950.0% | 0.00% | – |
Q3 2016 | $600,000 | -17.4% | 54,025 | -10.1% | 0.00% | – |
Q2 2016 | $726,000 | +20.0% | 60,091 | -5.5% | 0.00% | – |
Q1 2016 | $605,000 | +26.3% | 63,574 | +43.2% | 0.00% | – |
Q4 2015 | $479,000 | +2.6% | 44,386 | +3.3% | 0.00% | – |
Q3 2015 | $467,000 | – | 42,984 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |